期刊文献+

突变型乙肝病毒前C-C基因疫苗免疫BALB/C小鼠的研究 被引量:2

Immune effects of mutated Hepatitis B Virus precore-core DNA vaccines in mice
原文传递
导出
摘要 目的了解乙肝病毒前C-C基因疫苗(VEC)的突变型VE2、VE4免疫BALB/c小鼠后诱发特异性体液和细胞免疫的效果。方法分别用突变型和非突变型DNA疫苗免疫BALB/c小鼠,ELISA法检测小鼠抗HBc、抗HBeIgG,免疫第28天取小鼠脾细胞用酶免疫斑点(ELISpot)方法和CTL杀伤试验检测特异性细胞免疫功能。结果VE2、VFA组抗HBe水平高于VEC组,抗HBc水平差异无统计学意义。3种质粒均能引发特异性细胞免疫反应,VE4、VE2强于VEC;联用VM7免疫后能使VEC、VE2、VFA特异性细胞免疫反应增强。结论突变型前C-C基因疫苗在诱导BALB/c小鼠特异性体液和细胞免疫方面优于突变前。7干扰索基因可作为基因佐剂增强HBVDNA疫苗诱导的特异性细胞免疫反应。 Objective To observe the immune effect of DNA vaccines encoding mutated HBV pre-c/c gene(VE2,VFA) in mice. Methods Three kinds of plasmid VEC(DNA vaccines encoding HBV pre-c/c gene), VE2 and VEA were injected into the thigh muscles of different group of BALB/c mice. Blood and splenocytes from mice were isolated at 4 weeks after immunization. We also have mouse groups immunized with three of these plasmid combined with IFN-γ gene plasmids. The anti-HBc and anti-HBe antibody in peripheral blood in mice were detected by enzyme linked immunosorbent assay(ELISA), antigen-specific cell immune responses were detected by CTL test and enzyme linked immunospot assay(ELISpot). Results We found that anti-HBe titers of VE2 and VE4 immunizing groups are higher than VEC group (P〈0.05 ) . We also observed that VE2 and VFA could induce stronger antigen-specific immune responses than VEC and when combined with IFN-γ plasmid,the antigen-specific immune responses are stronger than those without combination immunization in mice (P〈0.05). Conclusions The DNA vaccine VE2 and VE4 could induces stronger antigen-specific immune responses than VEC, and when combined with IFN-γ plasmid, the antigen-specific immune responses are improved in mice.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 北大核心 2008年第6期446-448,共3页 Chinese Journal of Experimental and Clinical Virology
关键词 肝炎 乙型 疫苗 DNA Pre-C抗原 免疫酶技术 免疫 细胞 Hepatitis B Vaccines, DNA Pre- C antigen Immunoengyme techniques Immunity, cellular
  • 相关文献

参考文献7

  • 1Rajcani J, Mosko T, Rezuchova I. Current developments in viral DNA vaccines:shall they solve the unsolved?. Rev Med Virol,2005, 15: 303-325.
  • 2Yan J, Liu X, Wang Y, et al. Enhancing the potency of HBV DNA vaccines using fusion genes of HBV-spocific antigens and the N- terminal fragment of gp96. J Gene Med,2007,9:107-121.
  • 3赫兢,辛绍杰,毛远丽,王海滨,周讯,杨健洋,孔维,貌盼勇.乙型肝炎病毒复制调控元件对HBV DNA疫苗诱导的免疫应答[J].中华传染病杂志,2006,24(5):311-315. 被引量:5
  • 4Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology, 2003, 38: 1075- 1086.
  • 5张敏,辛绍杰,段学章,侯俊,胡燕,沈宏辉,貌盼勇.单引物二次PCR法对重组质粒中HBV前C-C基因进行点突变的研究[J].中华检验医学杂志,2007,30(4):444-446. 被引量:3
  • 6Chen A, Wang L, Zhang J. H-2 Kd-restricted hepatitis B virus-derived epitope whose specific CD8^+ T lymphocytes can produce gamma interferon without cytotoxicity. J Virol, 2005,79 : 5568-5576.
  • 7Messageot F, Salhi S, Eon P, et al. Proteolytic processing of the hepatitis B virus e antigen precursor. Cleavage at two furin consensus sequences. J Binl Chem, 2003,278 : 891-895.

二级参考文献7

  • 1Ling-Ling Tang,Ke-Zhou Liu From the Institute of Infectious Diseases, Zhejang University School of Medicine, Hangzhou 3110003, China.Recent advances in DNA vaccine of hepatitis virus[J].Hepatobiliary & Pancreatic Diseases International,2002,1(2):228-231. 被引量:5
  • 2Weiner MP, Costa GL, Schoetthn W, et al. Site-directed mutagenesis of double-stranded DNA by the polymerase chain reaction. Gene, 1994,151 : 119-123.
  • 3Rabhi I, Guedel N, Chouk I, et al. A novel simple and rapid PCR-based site-directed mutagenesis method. Mol Biotechnol,2004,26:27 -34.
  • 4Wang W, Malcolm BA. Two-stage PCR protocol allowing introduction of multiple mutations, deletions and insertions using QuickChange Site-Directed Mutagenesis. Biotechniques, 1999,26 : 680-682.
  • 5Parikh A, Guengerich FP. Random mutagenesis by whole-plasmid PCR amplification. Biotechniques, 1998,24: 428-431.
  • 6Allemandou F, Nussberger J, Brunner HR, et al. Rapid site-directed mutagenesis using Two-PCR-Generated DNA fragments reproducing the plasmid template. J Biomed Biotechnol, 2003,2003 : 202-207.
  • 7张涛,曾霞,王树声.乙肝DNA疫苗的研究进展[J].广西预防医学,2001,7(3):177-180. 被引量:1

共引文献6

同被引文献14

  • 1Stephan Menne,Paul J Cote.The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection[J].World Journal of Gastroenterology,2007,13(1):104-124. 被引量:23
  • 2李敏然(综述),孙殿兴(综述),李兵顺(审校).乙型肝炎病毒动物模型的研究现状[J].国际病毒学杂志,2007,14(1):5-10. 被引量:2
  • 3胡静,姚云清.鸭乙型肝炎病毒模型的研究意义[J].检验医学与临床,2007,4(4):284-285. 被引量:2
  • 4林春鑫,吴婷,伍小路,谢明辉,程通,李少伟,张军,夏宁邵.戊肝病毒Th表位肽免疫可增强其载体蛋白的体液免疫应答[J].生物工程学报,2007,23(2):310-314. 被引量:1
  • 5Kreher C R,Dittrich M T,Guerkov R,et al.CD4+ and CD8+cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays[J].J Immunol Methods,2003,278(1-2):79-93.
  • 6Fauci A S,Touchette N A,Folkers G K.Emerging infectious diseases:a 10-year perspective from the National Institute of Allergy and Infectious Diseases[J].Emerg Infect Dis,2005,11(4):519-525.
  • 7Xu Y,Theobald V,Sung C,et al.Validation of a HLA-A2 tetramer flow cytometric method,IFNgamma real time RT-PCR,and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients[J].J Transl Med,2008,6:61.
  • 8Cheng X,Eisenbraun M,Xu Q,et al.H5NI vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines[J].PLoS One,2009,4(2):e4436.
  • 9Streeck H,Frahm N,Walker B D.The role of IFN-gamma Elispot assay in HIV vaccine research[J].Nat Protoc,2009,4(4):461-469.
  • 10Sundar K,Boesen A,Coico R.Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes[J] Virology,2007,360(2):257-263.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部